Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeremy Shapiro

Showing results (41-50 of 76) with videos related to

Pageof 8
Sort By:
Asia-Pacific Journal of Clinical Oncology|April 15, 2015
Novel quality indicators for metastatic colorectal cancer management identify significant variations in these measures across treatment centers in AustraliaNatalie Heather Turner, Hui-Li Wong, Kathryn Field, et al.
Acta Oncologica (Stockholm, Sweden)|July 24, 2018
The survival outcome of patients with metastatic colorectal cancer based on the site of metastases and the impact of molecular markers and site of primary cancer on metastatic patternThiru Prasanna, Christos S Karapetis, David Roder, et al.
World Journal of Gastroenterology|May 9, 2015
Gastrointestinal perforation in metastatic colorectal cancer patients with peritoneal metastases receiving bevacizumabAflah Roohullah, Hui-Li Wong, Katrin M Sjoquist, et al.
Pharmacoeconomics|August 18, 2020
Simulating Progression-Free and Overall Survival for First-Line Doublet Chemotherapy With or Without Bevacizumab in Metastatic Colorectal Cancer Patients Based on Real-World Registry DataKoen Degeling, Hui-Li Wong, Hendrik Koffijberg, et al.
Asia-Pacific Journal of Clinical Oncology|February 15, 2019
Right versus left sided metastatic colorectal cancer: Teasing out clinicopathologic drivers of disparity in survivalShehara Mendis, Sophie Beck, Belinda Lee, et al.
International Journal of Surgery (London, England)|January 26, 2018
Immunohistochemistry testing for mismatch repair deficiency in Stage 2 colon cancer: A cohort study of two cancer centresMatthew Grant, Andrew Haydon, Lewis Au, et al.
Asia-Pacific Journal of Clinical Oncology|March 17, 2017
How accurate are medical oncologists' impressions of management of metastatic colorectal cancer in Australia?Lewis Au, Natalie Turner, Hui-Li Wong, et al.
Clinical Colorectal Cancer|July 1, 2018
Previous Bevacizumab and Efficacy of Later Anti-Epidermal Growth Factor Receptor Antibodies in Metastatic Colorectal Cancer: Results From a Large International RegistryMatthew Burge, Christine Semira, Belinda Lee, et al.
Clinical Colorectal Cancer|July 22, 2021
Treatment and Outcomes of Oligometastatic Colorectal Cancer Limited to Lymph Node MetastasesVinod Kalapurackal Mathai, Soe Yu Aung, Vanessa Wong, et al.
Expert Review of Anticancer Therapy|November 5, 2021
Update on optimal management for pancreatic cancer: expert perspectives from members of the Australasian Gastrointestinal Trials Group (AGITG) with invited international facultyMike Nguyen, Eva Segelov, David Goldstein, et al.
Pageof 8

Showing results (41-50 of 76) with videos related to

Sort By:
Pageof 8
Asia-Pacific Journal of Clinical Oncology|April 15, 2015
Novel quality indicators for metastatic colorectal cancer management identify significant variations in these measures across treatment centers in AustraliaNatalie Heather Turner, Hui-Li Wong, Kathryn Field, et al.
Acta Oncologica (Stockholm, Sweden)|July 24, 2018
The survival outcome of patients with metastatic colorectal cancer based on the site of metastases and the impact of molecular markers and site of primary cancer on metastatic patternThiru Prasanna, Christos S Karapetis, David Roder, et al.
World Journal of Gastroenterology|May 9, 2015
Gastrointestinal perforation in metastatic colorectal cancer patients with peritoneal metastases receiving bevacizumabAflah Roohullah, Hui-Li Wong, Katrin M Sjoquist, et al.
Pharmacoeconomics|August 18, 2020
Simulating Progression-Free and Overall Survival for First-Line Doublet Chemotherapy With or Without Bevacizumab in Metastatic Colorectal Cancer Patients Based on Real-World Registry DataKoen Degeling, Hui-Li Wong, Hendrik Koffijberg, et al.
Asia-Pacific Journal of Clinical Oncology|February 15, 2019
Right versus left sided metastatic colorectal cancer: Teasing out clinicopathologic drivers of disparity in survivalShehara Mendis, Sophie Beck, Belinda Lee, et al.
International Journal of Surgery (London, England)|January 26, 2018
Immunohistochemistry testing for mismatch repair deficiency in Stage 2 colon cancer: A cohort study of two cancer centresMatthew Grant, Andrew Haydon, Lewis Au, et al.
Asia-Pacific Journal of Clinical Oncology|March 17, 2017
How accurate are medical oncologists' impressions of management of metastatic colorectal cancer in Australia?Lewis Au, Natalie Turner, Hui-Li Wong, et al.
Clinical Colorectal Cancer|July 1, 2018
Previous Bevacizumab and Efficacy of Later Anti-Epidermal Growth Factor Receptor Antibodies in Metastatic Colorectal Cancer: Results From a Large International RegistryMatthew Burge, Christine Semira, Belinda Lee, et al.
Clinical Colorectal Cancer|July 22, 2021
Treatment and Outcomes of Oligometastatic Colorectal Cancer Limited to Lymph Node MetastasesVinod Kalapurackal Mathai, Soe Yu Aung, Vanessa Wong, et al.
Expert Review of Anticancer Therapy|November 5, 2021
Update on optimal management for pancreatic cancer: expert perspectives from members of the Australasian Gastrointestinal Trials Group (AGITG) with invited international facultyMike Nguyen, Eva Segelov, David Goldstein, et al.
Pageof 8